(DBEF) MSCI EAFE Hedged Equity - Overview
Etf: Developed-Market, Stocks, Currency-Hedge
Dividends
| Dividend Yield | 5.91% |
| Yield on Cost 5y | 10.13% |
| Yield CAGR 5y | 31.42% |
| Payout Consistency | 70.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 11.5% |
| Relative Tail Risk | 3.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.23 |
| Alpha | 11.61 |
| Character TTM | |
|---|---|
| Beta | 0.730 |
| Beta Downside | 0.826 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.62% |
| CAGR/Max DD | 1.25 |
Description: DBEF MSCI EAFE Hedged Equity January 07, 2026
The Xtrackers MSCI EAFE Hedged Equity ETF (DBEF) employs a passive, index-tracking strategy that aims to mirror the pre-fee performance of its underlying MSCI EAFE index while neutralising currency risk between the U.S. dollar and the local currencies of the constituent markets. At least 80 % of the fund’s assets are invested directly in the index’s component securities, and the fund is classified as non-diversified under regulatory definitions.
Key data points to consider: the fund’s expense ratio is 0.20 % (annualized), and as of the latest reporting it holds roughly $1.2 billion in assets under management, with a weighted average dividend yield near 2.3 %. The hedging overlay typically adds 0.5-1.0 % of annual return in periods of a strong dollar, but can also erode performance when the dollar weakens. Sector exposure is heavily weighted toward financials (≈20 %) and consumer discretionary (≈18 %), making the ETF sensitive to European and Japanese GDP growth rates and central-bank policy shifts.
If you want a more granular, data-driven view of DBEF’s risk-return profile, ValueRay’s analytics platform offers a convenient deep-dive.
What is the price of DBEF shares?
Over the past week, the price has changed by +1.85%, over one month by +2.79%, over three months by +8.78% and over the past year by +24.11%.
Is DBEF a buy, sell or hold?
What are the forecasts/targets for the DBEF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 64.2 | 25.2% |
DBEF Fundamental Data Overview February 09, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 8.51b USD (8.51b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 8.51b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 8.51b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.61% (E(8.51b)/V(8.51b) * Re(8.61%) + (debt-free company))
Discount Rate = 8.61% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)